News
More evidence MIS-C is a delayed response to SARS-CoV-2
April 13, 2021
CDC analysis of the largest cohort of MIS-C cases in the United States to date shows three temporal peaks of diagnoses in the United States and further validates the “prevailing hypothesis that MIS-C is a postinfectious mediated disorder.”
News
Novel antiplatelet drug: Hope for efficacy without bleeding?
April 12, 2021
A new antiplatelet drug with a completely novel mechanism of action could hold the promise of delivering the holy grail – reducing cardiac events without increasing bleeding.
![1]()
News
Longitudinal associations between income changes and incident CVD
April 2, 2021
Is there an association between income change and cardiovascular disease (CVD)?
News
AstraZeneca COVID vaccine: Clotting disorder mechanism revealed?
April 2, 2021
The vaccine may be linked to a condition that clinically resembles heparin-induced thrombocytopenia and seems to occur mainly in younger women.
News
The role of aspirin in primary prevention of cardiovascular disease
April 1, 2021
Does aspirin have a role in primary prevention of cardiovascular disease?
![1]()
News
PCI and CABG for left main disease have equal outcomes at 5 years
March 31, 2021
In a patient with left main coronary disease, is percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) a better option when considering long-term (5-year) outcomes?
![1]()
News
In-hospital mobility impairment in older MI patients predicts postdischarge functional decline
March 29, 2021
Does in-hospital mobility of older patients hospitalized for acute myocardial infarction predict overall functional decline after discharge?
![1]()
News
Dapagliflozin may cut risk of HF hospitalization in patients with type 2 diabetes
March 25, 2021
What is the Food and Drug Administration–approved indication for dapagliflozin (Farxiga)?
News
Low concordance between troponin assays for ACS
March 25, 2021
Concordance between high-sensitivity troponin assays was only 37% for a single blood draw, rising to 75% with serial testing, but still changing management decisions in some patients.
![1]()
News
ApoB may better predict mortality risk in statin-treated patients
March 24, 2021
In the study, measures of apoB and non-HDL cholesterol, but not LDL cholesterol, were associated with increased residual mortality and myocardial infarction risk.
